Literature DB >> 33652809

Internal and External Validity of Social Media and Mobile Technology-Driven HPV Vaccination Interventions: Systematic Review Using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) Framework.

Matthew Asare1, Braden Popelsky1, Emmanuel Akowuah1, Beth A Lanning1, Jane R Montealegre2.   

Abstract

Social media human papillomavirus (HPV) vaccination interventions show promise for increasing HPV vaccination rates. An important consideration for the implementation of effective interventions into real-world practice is the translation potential, or external validity, of the intervention. To this end, we conducted a systematic literature review to describe the current body of evidence regarding the external validity of social media HPV vaccination-related interventions. Constructs related to external validity were based on the reach, effectiveness, adoption, implementation, maintenance (RE-AIM) framework. Seventeen articles published between 2006 and 2020 met the inclusion criteria. Three researchers independently coded each article using a validated RE-AIM framework. Discrepant codes were discussed with a fourth reviewer to gain consensus. Of these 17 studies, 3 were pilot efficacy studies, 10 were randomized controlled trials (RCTs) to evaluate effectiveness, 1 was a population-based study, and 3 did not explicitly state which type of study was conducted. Reflecting this distribution of study types, across all studies the mean level of reporting RE-AIM dimensions varied with reach recording 90.8%, effectiveness (72.1%), adoption (40.3%), implementation (45.6%), and maintenance (26.5%). This review suggests that while the current HPV vaccination social media-driven interventions provide sufficient information on internal validity (reach and effectiveness), few have aimed to gather data on external validity needed to translate the interventions into real world implementation. Our data suggest that implementation research is needed to move HPV vaccination-related interventions into practice. Included in this review are recommendations for enhancing the design and reporting of these HPV vaccination social media-related interventions.

Entities:  

Keywords:  HPV; HPV vaccine; HPV vaccine intervention; RE-AIM Framework; mobile phone; social media

Year:  2021        PMID: 33652809      PMCID: PMC7996801          DOI: 10.3390/vaccines9030197

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  58 in total

Review 1.  The future of health behavior change research: what is needed to improve translation of research into health promotion practice?

Authors:  Russell E Glasgow; Lisa M Klesges; David A Dzewaltowski; Sheana S Bull; Paul Estabrooks
Journal:  Ann Behav Med       Date:  2004-02

2.  The importance of external validity.

Authors:  Allan Steckler; Kenneth R McLeroy
Journal:  Am J Public Health       Date:  2007-11-29       Impact factor: 9.308

Review 3.  The RE-AIM framework: a systematic review of use over time.

Authors:  Bridget Gaglio; Jo Ann Shoup; Russell E Glasgow
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

4.  Parental Choice of Recall Method for HPV Vaccination: A Pragmatic Trial.

Authors:  Allison Kempe; Sean T O'Leary; Jo Ann Shoup; Shannon Stokley; Steven Lockhart; Anna Furniss; L Miriam Dickinson; Juliana Barnard; Matthew F Daley
Journal:  Pediatrics       Date:  2016-02-26       Impact factor: 7.124

Review 5.  A systematic review of children's dietary interventions with parents as change agents: Application of the RE-AIM framework.

Authors:  Chelsey R Schlechter; Richard R Rosenkranz; Justin M Guagliano; David A Dzewaltowski
Journal:  Prev Med       Date:  2016-08-26       Impact factor: 4.018

6.  Impact of an HPV Education and Vaccination Campaign among Canadian University Students.

Authors:  Sabrina Piedimonte; Annie Leung; Andrew Zakhari; Céline Giordano; Pierre-Paul Tellier; Susie Lau
Journal:  J Obstet Gynaecol Can       Date:  2017-11-06

7.  A Storytelling Intervention in a Mobile, Web-Based Platform: A Pilot Randomized Controlled Trial to Evaluate the Preliminary Effectiveness to Promote Human Papillomavirus Vaccination in Korean American College Women.

Authors:  Minjin Kim; Haeok Lee; Peter Kiang; Teri Aronowitz; Lisa Kennedy Sheldon; Ling Shi; Jeroan J Allison
Journal:  Health Educ Behav       Date:  2020-01-20

8.  A randomized intervention study to evaluate whether electronic messaging can increase human papillomavirus vaccine completion and knowledge among college students.

Authors:  Alice R Richman; LaDonna Maddy; Essie Torres; Ellen J Goldberg
Journal:  J Am Coll Health       Date:  2016-01-29

Review 9.  Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.

Authors:  Dawn M Holman; Vicki Benard; Katherine B Roland; Meg Watson; Nicole Liddon; Shannon Stokley
Journal:  JAMA Pediatr       Date:  2014-01       Impact factor: 16.193

10.  Using the RE-AIM framework to evaluate internal and external validity of mobile phone-based interventions in diabetes self-management education and support.

Authors:  Yilin Yoshida; Sonal J Patil; Ross C Brownson; Suzanne A Boren; Min Kim; Rosie Dobson; Kayo Waki; Deborah A Greenwood; Astrid Torbjørnsen; Ambady Ramachandran; Christopher Masi; Vivian A Fonseca; Eduardo J Simoes
Journal:  J Am Med Inform Assoc       Date:  2020-06-01       Impact factor: 4.497

View more
  2 in total

1.  Adaptation and Dissemination of a National Cancer Institute HPV Vaccine Evidence-Based Cancer Control Program to the Social Media Messaging Environment.

Authors:  Suellen Hopfer; Kalani Kieu-Diem Phillips; Maxwell Weinzierl; Hannah E Vasquez; Sarah Alkhatib; Sanda M Harabagiu
Journal:  Front Digit Health       Date:  2022-07-27

2.  The impact of HPV vaccine narratives on social media: Testing narrative engagement theory with a diverse sample of young adults.

Authors:  Amy E Leader; Michelle Miller-Day; Rikishi T Rey; Preethi Selvan; Anne E Pezalla; Michael L Hecht
Journal:  Prev Med Rep       Date:  2022-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.